Jazz Pharmaceuticals PLC (JAZZ)
127.16
+2.06
(+1.65%)
USD |
NASDAQ |
Nov 22, 13:33
Jazz Pharmaceuticals Total Assets (Quarterly): 12.26B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 12.26B |
| June 30, 2024 | 11.36B |
| March 31, 2024 | 11.33B |
| December 31, 2023 | 11.39B |
| September 30, 2023 | 11.20B |
| June 30, 2023 | 11.26B |
| March 31, 2023 | 11.05B |
| December 31, 2022 | 10.84B |
| September 30, 2022 | 10.38B |
| June 30, 2022 | 11.20B |
| March 31, 2022 | 11.77B |
| December 31, 2021 | 12.30B |
| September 30, 2021 | 12.48B |
| June 30, 2021 | 13.21B |
| March 31, 2021 | 6.756B |
| December 31, 2020 | 6.536B |
| September 30, 2020 | 6.292B |
| June 30, 2020 | 6.067B |
| March 31, 2020 | 5.215B |
| December 31, 2019 | 5.539B |
| September 30, 2019 | 5.528B |
| June 30, 2019 | 5.489B |
| March 31, 2019 | 5.280B |
| December 31, 2018 | 5.203B |
| September 30, 2018 | 5.486B |
| Date | Value |
|---|---|
| June 30, 2018 | 5.349B |
| March 31, 2018 | 5.287B |
| December 31, 2017 | 5.124B |
| September 30, 2017 | 4.999B |
| June 30, 2017 | 4.804B |
| March 31, 2017 | 4.816B |
| December 31, 2016 | 4.800B |
| September 30, 2016 | 4.931B |
| June 30, 2016 | 3.448B |
| March 31, 2016 | 3.535B |
| December 31, 2015 | 3.333B |
| September 30, 2015 | 3.464B |
| June 30, 2015 | 3.393B |
| March 31, 2015 | 3.238B |
| December 31, 2014 | 3.339B |
| September 30, 2014 | 3.348B |
| June 30, 2014 | 3.156B |
| March 31, 2014 | 3.196B |
| December 31, 2013 | 2.238B |
| September 30, 2013 | 2.185B |
| June 30, 2013 | 2.094B |
| March 31, 2013 | 2.010B |
| December 31, 2012 | 1.966B |
| September 30, 2012 | 1.727B |
| June 30, 2012 | 1.698B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.215B
Minimum
Mar 2020
13.21B
Maximum
Jun 2021
9.922B
Average
11.20B
Median
Total Assets (Quarterly) Benchmarks
| Avadel Pharmaceuticals PLC | 158.25M |
| Alkermes PLC | 2.155B |
| Medtronic PLC | 90.04B |
| Perrigo Co PLC | 11.20B |
| Iterum Therapeutics PLC | 19.62M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.085B |
| Shareholders Equity (Quarterly) | 4.171B |
| Debt to Equity Ratio | 1.465 |
| Current Ratio | 4.263 |
| Net Debt Paydown Yield | -1.17% |